Personalized cancer vaccine including : DNA neoantigen vaccine, MVA viral vector and Ipilimumab (anti-CTLA4) clinical trials

Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer

This early-stage study is looking at a new, personalised vaccine treatment for advanced bowel or pancreatic cancer. It checks if the treatment is safe, possible to give, and if it helps control the cancer. Researchers are also figuring out the right dose.